Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001209191-21-052077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | 2021-08-17 | TVTX | Clague Laura | CFO | S - Sale | $17.12 | -1,407 | 31.3K | -4% | -$24.1K | |
| 2021-08-17 | 2021-08-13 | TVTX | Clague Laura | CFO | A - Grant | $0.00 | +4,500 | 32.7K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | S | D | 1,407 | $17.12 | 31,316 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-13 | A | A | 4,500 | $0.00 | 32,723 | D | — | — |